Change search
ReferencesLink to record
Permanent link

Direct link
Pulmonary Arterial Hypertension
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Medicine.
2010 (English)In: Heart Failure in Clinical Practice / [ed] Michael Y. Henein, Springer London, 2010, 153-163 p.Chapter in book (Refereed)
Abstract [en]

Pulmonary arterial hypertension (PAH) is a syndrome resulting from restricted flow of blood through the pulmonary arterial circulation due to increased pulmonary vascular resistance and is complicated ultimately by right heart failure. A number of pathological pathways are involved in the development of PAH, including those at the genetic and molecular levels, and arterial smooth muscle, endothelial cells and adventitia. The imbalance in the vasoconstrictor/vasodilator milieu represents the basis for current medical therapies, although PAH also involves an imbalance of proliferation and apoptosis. The present classification of pulmonary hypertension (PH) was established in 1998 at the World Congress of PH in Evian, and was later revised in Dana Point in 2008 (Table 7.1).

Place, publisher, year, edition, pages
Springer London, 2010. 153-163 p.
National Category
Cardiac and Cardiovascular Systems
URN: urn:nbn:se:umu:diva-75743DOI: 10.1007/978-1-84996-153-0_7ISI: 000284026100007ISBN: 978-1-84996-152-3ISBN: 978-1-84996-153-0OAI: diva2:635466
Available from: 2013-07-04 Created: 2013-07-03 Last updated: 2013-07-04Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Söderberg, Stefan
By organisation
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 62 hits
ReferencesLink to record
Permanent link

Direct link